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ABSTRACT
The early progression of diabetic nephropathy is notoriously difficult to detect and quantify prior to the occurrence of substantial histological damage. Recently, hyperpolarized [1- 13 C] pyruvate has demonstrated increased lactate production in the kidney early after the onset of diabetes, implying increased lactate dehydrogenase activity as a consequence of increased nicotinamide adenine dinucleotide substrate availability due to upregulation of the polyol pathway, i.e., pseudohypoxia. In this study, we investigated the role of oxidative stress in mediating these metabolic alterations using state-of-the-art hyperpolarized magnetic resonance (MR) imaging.
Ten-week-old female Wistar rats were randomly divided into three groups: healthy controls, untreated diabetic (streptozotocin treatment to induce insulinopenic diabetes), and diabetic, receiving chronic antioxidant treatment with TEMPOL (4-hydroxy-2,2,6,6-tetramethylpiperidin-1-oxyl) via the drinking water. Examinations were performed 2, 3, and 4 weeks after the induction of diabetes by using a 3T Clinical MR system equipped with a dual tuned 13 C/ 1 H-volume rat coil. The rats received intravenous hyperpolarized [1- 13 C] pyruvate and were imaged using a slice-selective 13 C-IDEAL spiral sequence.
Untreated diabetic rats showed increased renal lactate production compared to that shown by the controls. However, chronic TEMPOL treatment significantly attenuated diabetes-induced lactate production. No significant effects of diabetes or TEMPOL were observed on 13 C-alanine levels,
indicating an intact glucose-alanine cycle, or 13 C-bicarbonate, indicating normal flux through the Krebs cycle.
In conclusion, this study demonstrates that diabetes-induced pseudohypoxia, as indicated by an increased lactate-to-pyruvate ratio, is significantly attenuated by antioxidant treatment. This demonstrates a pivotal role of oxidative stress for renal metabolic alterations occurring in early diabetes.
INTRODUCTION
Patients diagnosed with developing diabetic nephropathy are left with current treatments that at best slow disease progression (19) . Thus, effective prevention and treatment of diabetic nephropathy requires a better understanding of the mechanisms involved in progressive kidney damage. Today, microalbuminuria is the preferred marker of diabetic nephropathy, but by the time microalbuminuria can be detected, abnormal renal structural changes have already occurred.
Hyperpolarized 13 C-labeled pyruvate was recently introduced as a possible alternative endogenous marker for the identification of renal metabolic alterations in diabetic rats. This technique allows for real-time repeated measurements of intrarenal metabolism during the development of kidney disease (5-7). Prolonged hyperglycemia causes altered oxygen metabolism via an increased flux through the polyol pathway, leading to imbalanced NADH/NAD + distribution, which in turn increases lactate formation even though sufficient oxygen is present for oxidative phosphorylation to occur. Such a metabolic alteration is commonly referred to as pseudohypoxia (25) . However, despite the name, pseudohypoxia will eventually result in the development of "true" renal hypoxia as the disease progresses (3, 15) . Thus, the balance between pseudohypoxic and hypoxic conditions has been proposed to be an indication of disease progression (5-7).
Oxidative stress has been reported to be a crucial component of diabetic nephropathy, and antioxidant treatment in animal models of diabetic nephropathy has generally resulted in reduction or even complete prevention of disease progression (24) . The relationship between increased oxidative stress and metabolic alterations in the diabetic kidney has not been established, although a close relationship between metabolic alteration and development of diabetic nephropathy has been reported (15). Therefore, we tested the hypothesis that chronic antioxidant treatment prevents pseudohypoxia in a rat model of insulinopenic diabetes using hyperpolarized metabolic imaging.
MATERIALS AND METHODS
Twenty-four ten-week-old female Wistar rats (Taconic, Ry, Denmark) were included in this study.
The rats were randomly grouped into an untreated diabetic group (n=14), a 4-hydroxy-2,2,6,6- animals with up to three examinations per animal. The examinations were performed at two, three, and four weeks after diabetes induction (Fig. 1A) . In order to identify the response to TEMPOL treatment a parallel group was investigated at only one time point consisting of untreated diabetic (N=4, test of difference with within-subject diabetic animals) and TEMPOL treated diabetic animals (N=8) at the terminal point (Fig. 1B) 
MRI Analysis
Data analysis of the hyperpolarized MR signal was processed using a vendor delivered Matlab (MathWorks, Natick, MA, USA) package, and the raw DICOM images were transferred to OsiriX (Pixmeo, Geneva, Switzerland) for anatomical overlay and region of interest (ROI) analysis. The metabolite signal was normalized relative to the pyruvate signal in each individual kidney.
Quantitative real-time PCR
After euthanasia, kidney cortices were rapidly dissected and snap-frozen in liquid nitrogen. Cortical tissue was homogenized and total RNA was isolated using a Nucleospin RNA II kit (Stratagene;
AH Diagnostics, Aarhus, DK) following the manufacturer's instructions. RNA purity and concentration was measured spectrophotometrically (Eppendorf Biophotometer, Hørsholm, Denmark). cDNA synthesis was performed on 0.5 µg RNA with a revert first strand cDNA synthesis kit (Thermo Scientific, Hvidovre, DK) according to the manufacturer's instructions.
Preparation of samples for qPCR was performed using Maxima SYBR Green qPCR master mix (Thermo Scientific, Hvidovre, DK), following the manufacturer's instructions. The qPCR protocol consisted of 40 cycles of: denaturation for 30 seconds at 95°C followed by annealing and synthesis for 1 min at 60°C, and was performed in a 96-well qPCR plate using an AriaMx PCR system (Agilent Technology, Glostrup, Denmark). Primer information for each individual gene is presented in Table 1 .
Biochemical assays and ELISA for KIM-1 and NGAL
Fumarate, lactate and succinate assays (Sigma-Aldrich) and ELISA for Kidney injury marker 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) ELISA (Abcam, Cambridge, UK)
were performed according to the manufacturer's instructions In brief, kidney cortex tissue was snap-frozen in liquid nitrogen. Thereafter, tissue was homogenized in assay buffer specific for each assay; the homogenate centrifuged, and assays and ELISA performed on the resultant supernatant.
Blood was collected from the abdominal aorta, transferred to heparin tubes and centrifuged to isolate the plasma fraction. All samples were stored at -80•C. Analysis was performed in 96-well
Costar plates in a PHERAstar FS micro plate reader (BMG Labtech, Birkerød, Denmark). The full absorbance spectrum was determined for each wavelength in order to optimize each assay.
Statistics
Normality was assessed with quantile plots. Two-sided p<0.05 was considered statistically The group differences at the terminal point (Fig. 1B) to investigate the treatment response to TEMPOL and the biochemical analysis were performed using a one-way-ANOVA with Fisher post hoc correction using GraphPad, Prism (GraphPad Inc. La Jolla, CA, USA).
RESULTS
Administration of STZ resulted in hyperglycemia within 48h, and blood glucose levels remained significantly elevated throughout the study period (p<0.0001; Fig. 2 ). Diabetic animals developed pronounced renal hypertrophy (p<0.0001), while total body weight did not significantly differ between the groups (p=0.3; Fig. 2 ). Chronic TEMPOL treatment to diabetic animals did not significantly affect any of these parameters compared to the untreated diabetic group (Fig. 2) .
The lactate-to-pyruvate ratio was significantly elevated in the diabetic kidney at three weeks (+38% versus healthy controls; p=0.01) and further increased (+77% versus healthy control; p=0.001) at four weeks after the induction of diabetes (Fig. 3 , Table 2 ). No significant time-dependent changes between healthy controls and diabetic rats were observed for either alanine-to-pyruvate or bicarbonate-to-pyruvate ratios, although a significant overall time dependency was found in the bicarbonate-to-pyruvate ratio (Fig. 3 , Table 2 ). Chronic TEMPOL treatment significantly reduced lactate production (p=0.03) compared to untreated diabetic rats, but had no effect on alanine (p=0.47) or bicarbonate levels (p=0.11; Fig. 4 ).
The mRNA expression of lactate dehydrogenase was significantly elevated in the diabetic group compared to healthy controls (p=0.01). Chronic TEMPOL treatment significantly attenuated this increase, as treated animals presented a similar expression level as controls (p=0.5; Fig. 5 ). mRNA expression of pyruvate dehydrogenase (p=0.09) and alanine transferase (p=0.2) was similar in all groups (Fig. 5) . No significant differences were observed in mRNA expression of oxygen-sensitive genes, kidney injury markers, or inflammation markers (Fig. 6) between controls and diabetic animals with and without chronic TEMPOL treatment (Fig. 8) .
DISCUSSION
The main finding of this study was that antioxidant treatment with TEMPOL attenuated diabetesinduced lactate formation, and thus improved the lactate-to-pyruvate ratio in diabetic animals. This finding implies improved metabolic status secondary to reduced pseudohypoxia and supports the use of hyperpolarized [1-13 C] pyruvate as a biomarker for renal metabolic status under different treatment regimens. TEMPOL is a potent antioxidant known to prevent oxidative stress and to improve insulin sensitivity (2) . Interestingly, we have recently shown that suboptimal insulin treatment does not improve the lactate-to-pyruvate ratio (5), indicating that the main mechanism for the phenomenon seen in TEMPOL-treated animals is likely due to direct antioxidant effects.
The diabetic kidney suffers from altered metabolism, manifesting as increased total oxygen consumption secondary to increased mitochondrial leak respiration and decreased tubular electrolyte transport efficiency (4). Furthermore, increased metabolic flux via the polyol pathway causing altered cellular NADH/NAD + ratio results in increased lactate production and increased lactate-to-pyruvate ratio despite sufficient oxygen availability for oxidative phosphorylation (3).
This condition is therefore commonly referred to as "pseudohypoxia." (25) . It has been demonstrated that the inhibition of aldose reductase, the initial step in the polyol pathway, effectively prevents increased lactate formation and the subsequent reduction of the interstitial pH in the diabetic kidney (15). Indeed, most data supporting an altered NADH/NAD + ratio originate from in vitro experiments (13) due to the methodological difficulties in obtaining reliable and reproducible results from in vivo approaches. The present study demonstrates, using a non-invasive imaging method that only requires an intravenous injection of the tracer, a novel link between oxidative stress and pseudohypoxia in the diabetic kidney. This provides an additional mechanistic explanation for the beneficial effects of antioxidant treatment on diabetic kidney function (14, 17) .
The lactate-to-pyruvate ratio depends on the degree of diabetes-induced kidney damage, whereas alanine transferase and pyruvate dehydrogenase activity seems to be largely unaffected. This is in agreement with our previous findings, which reported increased intrarenal lactate-to-pyruvate ratios in insulinopenic rats (5-7). Furthermore, a time-dependent accumulation of lactate in the diabetic kidney has been previously reported as well (8 However, it was previously demonstrated that treatment with an NOX1/NOX4 inhibitor decreased fumarate levels, implying a pivotal involvement of oxidative stress. This is in agreement with the results from the present study demonstrating that the antioxidant TEMPOL significantly alters this metabolic pathway. However, it should be noted that PDH flux was unaltered and that leak respiration provides a substantial contribution to total kidney oxygen consumption in diabetes (17) .
Necrosis and subsequent cellular leak could be a potential mechanism for increased extracellular concentrations of TCA metabolites (21, 26) . Although the lactate-to-pyruvate ratio was significantly increased in the diabetic kidney, the mRNA expression of oxygen-sensitive and renal dysregulation genes were not altered, suggesting an earlier identification of the renal abnormalities observed using hyperpolarized MR.
Biomarkers for kidney injury, such as NGAL and KIM1, have been demonstrated to correlate with loss of kidney function in patients with type-2 diabetes (12). Elevated levels of these kidney injury markers have also been reported in experimental models of insulinopenic diabetes (1, 22, 23) .
However, KIM1 is not an independent predictor for progression of diabetic nephropathy in patients with type 1 diabetes when adjusted for albumin excretion rate (16) . Given the available data, NGAL and KIM1 might provide better prediction of kidney outcome in the setting of acute kidney injury compared to the more chronic setting of diabetic nephropathy. Although the results from the present study tend to imply increased NGAL and KIM1 in diabetic rats chronically treated with TEMPOL, it is unclear how this translates to long-term outcome given the lack of solid literature support for a relationship between these biomarkers and progression of diabetic nephropathy. Indeed, previous reports have demonstrated a time-dependent regulation of these genes (9, 18) . The efficiency of the antioxidant treatment is most likely time-dependent, i.e. earlier treatment initiation after the onset of diabetes leads to more potent effects. This may further explain why clinical trials investigating the use of antioxidants as a strategy to treat ongoing diabetic nephropathy have failed (20) . It should also be noted that clinically available substances are relatively weak antioxidants compared with TEMPOL, which may contribute to the ineffective outcomes of these trails (10) .
The ability to assess lactate-to-pyruvate conversion non-invasively within seconds, in combination with standard anatomical and functional MR measurements, and the recent introduction of hyperpolarized MR in human subjects (11) argue in favor of the introduction of this modality for the assessment and therapeutic monitoring of diabetic nephropathy, facilitating the introduction of valuable novel metabolic information for clinicians.
Summary and Significance
Pseudohypoxia has classically been considered resultant of an altered NADH/NAD + ratio secondary to increased metabolic flux via the polyol pathway. However, the present study demonstrated that antioxidant treatment of insulinopenic rats with TEMPOL significantly reduced the lactate-to-pyruvate ratio, which is an indication of reduced pseudohypoxia. A link between increased diabetes-induced oxidative stress and pseudohypoxia in the kidney has so far not been established.
These results provide an additional mechanistic explanation for the beneficial effects of reduced oxidative stress for diabetic kidney function. However, the finding of greater metabolic abnormalities with disease progression indicates that interventions are likely to be more effective if initiated early on after the onset of diabetes. Furthermore, the results demonstrate that the use of the lactate-to-pyruvate ratio as a biomarker of disease development is far more sensitive compared to classical markers such as NGAL and KIM-1. An early and sensitive biomarker for diabetic nephropathy would allow for early interventional studies, which are urgently needed since no effective treatment strategy to fight disease progression, outside minimizing known risk factors, is currently available. 
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